| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |